1. Association Study of the Tumor Necrosis Factor-α Gene and Its 1A Receptor Gene with Methamphetamine Dependence.
- Author
-
NOMURA, A., UJIKE, H., TANAKA, Y., KISHIMOTO, M., OTANI, K., MORITA, Y., MORIO, A., HARANO, M., INADA, T., YAMADA, M., KOMIYAMA, T., HORI, T., SEKINE, Y., IWATA, N., SORA, I., IYO, M., OZAKI, N., and KURODA, S.
- Subjects
- *
TUMOR necrosis factors , *METHAMPHETAMINE , *SUBSTANCE abuse , *BRAIN , *GENETIC polymorphisms , *GENES - Abstract
Recent preclinical findings that repeated treatment with methamphetamine (METH) induced an increase in tumor necrosis factor-α (TNF-α) mRNA in some brain regions and that TNF-α blocked METH neurotoxicity and rewarding effects suggest TNF-α, a multifunctional pro-inflammatory cytokine, may be involved in METH dependence. We hypothesized that genetic polymorphisms of the TNF-α gene and its receptor genes may be associated with vulnerability to METH dependence. Genetic association of -308G>A and -857C>T in the promotor region of the TNF-α gene, and 36A>G in exon 1 of the TNF receptor 1A gene (TNFR-SF1A), were analyzed in patients with METH dependence ( n= 185) and healthy controls ( n= 221) in a Japanese population. No significant association of alleles or haplotypes of the TNF-α or TNFR-SF1A genes with METH dependence was found. Neither was any significant association of clinical phenotype with METH dependence found. These results suggest that genetic variations in the TNF-α gene and its receptor genes may not be involved in individual vulnerability to METH dependence. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF